1. Home
  2. PVLA vs HUYA Comparison

PVLA vs HUYA Comparison

Compare PVLA & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$82.38

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo HUYA Inc. American depositary shares each  representing one ordinary share

HUYA

HUYA Inc. American depositary shares each representing one ordinary share

HOLD

Current Price

$4.64

Market Cap

989.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PVLA
HUYA
Founded
2015
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
989.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
PVLA
HUYA
Price
$82.38
$4.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
1
Target Price
$145.24
$3.50
AVG Volume (30 Days)
243.4K
3.4M
Earning Date
11-11-2025
03-17-2026
Dividend Yield
N/A
53.43%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$879,277,448.00
Revenue This Year
N/A
$9.05
Revenue Next Year
N/A
$11.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.40
52 Week Low
$14.60
$2.21
52 Week High
$114.69
$4.69

Technical Indicators

Market Signals
Indicator
PVLA
HUYA
Relative Strength Index (RSI) 41.52 72.47
Support Level $74.40 $4.20
Resistance Level $83.47 $4.64
Average True Range (ATR) 5.91 0.33
MACD -1.09 0.05
Stochastic Oscillator 27.30 96.08

Price Performance

Historical Comparison
PVLA
HUYA

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About HUYA HUYA Inc. American depositary shares each representing one ordinary share

Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.

Share on Social Networks: